About the Authors
- E. Camilla Forsberg, Susan S Prohaska, Garrett C Heffner, Irving L Weissman
- Departments of Pathology and Developmental Biology, Institute of Cancer and Stem Cell Biology and Medicine, Stanford University Medical School, Stanford, California, United States of America
- Sol Katzman, Josh M Stuart
- Biomolecular Engineering, University of California at Santa Cruz, Santa Cruz, California, United States of America
As a former advisory board member of Amgen, ILW owns significant Amgen stock. He also cofounded and consulted for Systemix; cofounded Cellerant Therapeutics, a spin-off from Systemix Novartis to transplant human HSC; and is a cofounder and a director of the company Stem Cells, which is involved in the isolation and study of human central nervous system stem cells, liver-repopulating cells, and pancreatic islet/progenitor cells.
ECF, SSP, and ILW conceived and designed the experiments. ECF, SSP and GCH performed the experiments. All authors analyzed the data. SK and JMS contributed reagents/materials/analysis tools. ECF wrote the paper.